Cranbury Pharmaceuticals

Cranbury Pharmaceuticals, a subsidiary of Tris Pharma, focuses on the development and commercialization of high-quality, patient-friendly products, leveraging the company's strengths in product selection, development, and commercial launch. Driven by patient-centered innovation, Cranbury will market more than 20 generic products and advance a diversified pipeline, ready to transform new ideas into approved and effective medicines.